JP4999847B2 - 感染防止のための不織布材料の抗微生物処理 - Google Patents
感染防止のための不織布材料の抗微生物処理 Download PDFInfo
- Publication number
- JP4999847B2 JP4999847B2 JP2008529261A JP2008529261A JP4999847B2 JP 4999847 B2 JP4999847 B2 JP 4999847B2 JP 2008529261 A JP2008529261 A JP 2008529261A JP 2008529261 A JP2008529261 A JP 2008529261A JP 4999847 B2 JP4999847 B2 JP 4999847B2
- Authority
- JP
- Japan
- Prior art keywords
- antimicrobial
- substrate
- article
- phmb
- microorganisms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000000845 anti-microbial effect Effects 0.000 title claims description 190
- 239000000463 material Substances 0.000 title claims description 115
- 238000011282 treatment Methods 0.000 title description 41
- 208000015181 infectious disease Diseases 0.000 title description 20
- 230000002265 prevention Effects 0.000 title description 3
- 239000000758 substrate Substances 0.000 claims description 159
- 239000000203 mixture Substances 0.000 claims description 129
- 239000000126 substance Substances 0.000 claims description 84
- VAZJLPXFVQHDFB-UHFFFAOYSA-N 1-(diaminomethylidene)-2-hexylguanidine Polymers CCCCCCN=C(N)N=C(N)N VAZJLPXFVQHDFB-UHFFFAOYSA-N 0.000 claims description 79
- 229920002413 Polyhexanide Polymers 0.000 claims description 73
- 244000005700 microbiome Species 0.000 claims description 73
- 238000000576 coating method Methods 0.000 claims description 41
- 230000009467 reduction Effects 0.000 claims description 39
- 239000011248 coating agent Substances 0.000 claims description 36
- 239000000835 fiber Substances 0.000 claims description 30
- 239000004599 antimicrobial Substances 0.000 claims description 28
- 230000001681 protective effect Effects 0.000 claims description 24
- 239000002216 antistatic agent Substances 0.000 claims description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 14
- 239000013543 active substance Substances 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 10
- 229920006243 acrylic copolymer Polymers 0.000 claims description 4
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 3
- 229920002313 fluoropolymer Polymers 0.000 claims description 3
- 239000004811 fluoropolymer Substances 0.000 claims description 3
- 229960000789 guanidine hydrochloride Drugs 0.000 claims description 3
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- 229920002994 synthetic fiber Polymers 0.000 claims description 3
- 239000012209 synthetic fiber Substances 0.000 claims description 3
- 229920001169 thermoplastic Polymers 0.000 claims description 3
- 241000709661 Enterovirus Species 0.000 claims description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims 4
- 235000019270 ammonium chloride Nutrition 0.000 claims 2
- 206010041925 Staphylococcal infections Diseases 0.000 claims 1
- 208000037797 influenza A Diseases 0.000 claims 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 description 72
- 238000012360 testing method Methods 0.000 description 68
- 239000000243 solution Substances 0.000 description 41
- 239000003139 biocide Substances 0.000 description 33
- 241000894006 Bacteria Species 0.000 description 28
- 239000003795 chemical substances by application Substances 0.000 description 27
- 230000004888 barrier function Effects 0.000 description 24
- 230000008569 process Effects 0.000 description 23
- 239000003242 anti bacterial agent Substances 0.000 description 22
- 239000000047 product Substances 0.000 description 22
- 229940088710 antibiotic agent Drugs 0.000 description 21
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 230000002147 killing effect Effects 0.000 description 17
- 230000000813 microbial effect Effects 0.000 description 17
- 230000003115 biocidal effect Effects 0.000 description 16
- 230000000694 effects Effects 0.000 description 16
- 206010011409 Cross infection Diseases 0.000 description 15
- 230000001580 bacterial effect Effects 0.000 description 15
- 210000004379 membrane Anatomy 0.000 description 15
- 239000012528 membrane Substances 0.000 description 15
- 239000000645 desinfectant Substances 0.000 description 14
- 239000002054 inoculum Substances 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- 244000052769 pathogen Species 0.000 description 14
- 229920000642 polymer Polymers 0.000 description 14
- 239000004094 surface-active agent Substances 0.000 description 14
- 239000006057 Non-nutritive feed additive Substances 0.000 description 13
- 239000010410 layer Substances 0.000 description 13
- 238000003756 stirring Methods 0.000 description 13
- -1 quaternary ammonium siloxane Chemical class 0.000 description 12
- 230000003068 static effect Effects 0.000 description 12
- 229940123208 Biguanide Drugs 0.000 description 11
- 230000035515 penetration Effects 0.000 description 11
- 239000001913 cellulose Substances 0.000 description 10
- 229920002678 cellulose Polymers 0.000 description 10
- 235000010980 cellulose Nutrition 0.000 description 10
- 230000007423 decrease Effects 0.000 description 10
- 230000000699 topical effect Effects 0.000 description 10
- 229920001817 Agar Polymers 0.000 description 9
- 241000700605 Viruses Species 0.000 description 9
- 239000008272 agar Substances 0.000 description 9
- 239000010408 film Substances 0.000 description 9
- 238000002386 leaching Methods 0.000 description 9
- 230000003472 neutralizing effect Effects 0.000 description 9
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 8
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 8
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 8
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 8
- 238000012545 processing Methods 0.000 description 8
- 239000007921 spray Substances 0.000 description 8
- 230000002195 synergetic effect Effects 0.000 description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 7
- 229940098773 bovine serum albumin Drugs 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- 230000010534 mechanism of action Effects 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 6
- 241000233866 Fungi Species 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 230000000840 anti-viral effect Effects 0.000 description 6
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- 150000004283 biguanides Chemical group 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 210000000170 cell membrane Anatomy 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 6
- 229910021641 deionized water Inorganic materials 0.000 description 6
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 6
- 150000007524 organic acids Chemical class 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 239000004743 Polypropylene Substances 0.000 description 5
- 229920006362 Teflon® Polymers 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 230000000996 additive effect Effects 0.000 description 5
- 238000013019 agitation Methods 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000001332 colony forming effect Effects 0.000 description 5
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 238000007756 gravure coating Methods 0.000 description 5
- 230000008595 infiltration Effects 0.000 description 5
- 238000001764 infiltration Methods 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 150000002825 nitriles Chemical class 0.000 description 5
- 239000004745 nonwoven fabric Substances 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 150000003904 phospholipids Chemical class 0.000 description 5
- 239000002689 soil Substances 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 125000002091 cationic group Chemical group 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000011109 contamination Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000005611 electricity Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000001125 extrusion Methods 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 229920000126 latex Polymers 0.000 description 4
- 239000004816 latex Substances 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 150000002978 peroxides Chemical class 0.000 description 4
- 229920000098 polyolefin Polymers 0.000 description 4
- 229920001155 polypropylene Polymers 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000007639 printing Methods 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- 238000007763 reverse roll coating Methods 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 230000000087 stabilizing effect Effects 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 3
- 229920001661 Chitosan Polymers 0.000 description 3
- 239000004155 Chlorine dioxide Substances 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- 206010029803 Nosocomial infection Diseases 0.000 description 3
- 206010034133 Pathogen resistance Diseases 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 239000004809 Teflon Substances 0.000 description 3
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000007975 buffered saline Substances 0.000 description 3
- 229960002798 cetrimide Drugs 0.000 description 3
- 235000019398 chlorine dioxide Nutrition 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000000249 desinfective effect Effects 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 210000004247 hand Anatomy 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 125000001453 quaternary ammonium group Chemical group 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000003724 sodium stearoyl-2-lactylate Substances 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 238000007655 standard test method Methods 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 229960003500 triclosan Drugs 0.000 description 3
- 239000004034 viscosity adjusting agent Substances 0.000 description 3
- 229920003169 water-soluble polymer Polymers 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920000896 Ethulose Polymers 0.000 description 2
- 239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 239000012901 Milli-Q water Substances 0.000 description 2
- 229920002274 Nalgene Polymers 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 208000002847 Surgical Wound Diseases 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- 229910010413 TiO 2 Inorganic materials 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- LFVVNPBBFUSSHL-UHFFFAOYSA-N alexidine Chemical compound CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC LFVVNPBBFUSSHL-UHFFFAOYSA-N 0.000 description 2
- 229950010221 alexidine Drugs 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 235000020279 black tea Nutrition 0.000 description 2
- 244000078885 bloodborne pathogen Species 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 229920006317 cationic polymer Polymers 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000003196 chaotropic effect Effects 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 239000008199 coating composition Substances 0.000 description 2
- 230000009351 contact transmission Effects 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 208000028659 discharge Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000013013 elastic material Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 2
- 229960004068 hexachlorophene Drugs 0.000 description 2
- 239000003752 hydrotrope Substances 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000012633 leachable Substances 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 239000002018 neem oil Substances 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 238000000518 rheometry Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000003330 sporicidal effect Effects 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000011885 synergistic combination Substances 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 229940070527 tourmaline Drugs 0.000 description 2
- 229910052613 tourmaline Inorganic materials 0.000 description 2
- 239000011032 tourmaline Substances 0.000 description 2
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 2
- 208000019206 urinary tract infection Diseases 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- GUUULVAMQJLDSY-UHFFFAOYSA-N 4,5-dihydro-1,2-thiazole Chemical compound C1CC=NS1 GUUULVAMQJLDSY-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010305 Confusional state Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 229920001875 Ebonite Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 208000002979 Influenza in Birds Diseases 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 241000047703 Nonion Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 206010036410 Postoperative wound infection Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000031650 Surgical Wound Infection Diseases 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000012042 active reagent Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 244000000022 airborne pathogen Species 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000004760 aramid Substances 0.000 description 1
- 229920003235 aromatic polyamide Polymers 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 231100000704 bioconcentration Toxicity 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M bisulphate group Chemical group S([O-])(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000003103 bodily secretion Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- DKVNPHBNOWQYFE-UHFFFAOYSA-N carbamodithioic acid Chemical compound NC(S)=S DKVNPHBNOWQYFE-UHFFFAOYSA-N 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- NEUSVAOJNUQRTM-UHFFFAOYSA-N cetylpyridinium Chemical class CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NEUSVAOJNUQRTM-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- WSFMFXQNYPNYGG-UHFFFAOYSA-M dimethyl-octadecyl-(3-trimethoxysilylpropyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCC[Si](OC)(OC)OC WSFMFXQNYPNYGG-UHFFFAOYSA-M 0.000 description 1
- YOTZYFSGUCFUKA-UHFFFAOYSA-N dimethylphosphine Chemical class CPC YOTZYFSGUCFUKA-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000012990 dithiocarbamate Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000004070 electrodeposition Methods 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 238000007755 gap coating Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 229920001600 hydrophobic polymer Polymers 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000009474 immediate action Effects 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000937 inactivator Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000002346 layers by function Substances 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000004750 melt-blown nonwoven Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000007760 metering rod coating Methods 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 239000002068 microbial inoculum Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 229920006173 natural rubber latex Polymers 0.000 description 1
- 230000017066 negative regulation of growth Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 150000007523 nucleic acids Chemical group 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001748 polybutylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000012462 polypropylene substrate Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229920005992 thermoplastic resin Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000004764 thiosulfuric acid derivatives Chemical class 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000014599 transmission of virus Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 238000001771 vacuum deposition Methods 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003253 viricidal effect Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
- A01N47/42—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides containing —N=CX2 groups, e.g. isothiourea
- A01N47/44—Guanidine; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
- C08K5/0058—Biocides
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
- D06M15/19—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
- D06M15/37—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- D06M15/564—Polyureas, polyurethanes or other polymers having ureide or urethane links; Precondensation products forming them
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
- D06M15/19—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
- D06M15/37—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- D06M15/61—Polyamines polyimines
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M16/00—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
Description
Wwは、挟んだ後の浸透したサンプルの重量
Wdは、処理されるサンプルの乾燥重量
接種材料:8.08
ZOIとは、抑制領域(Zone of inhibition)のことである。
E481とは、Bermocoll EBS 481FQ(エチル・ヒドロキシエチル・セルロース)のことである。
PVPとは、ポリビニル・ピロリドンのことである。
(1)AATCC#147−1998の方法を変更した。
(2)ASTM E2149−01の方法を変更した。
(3)水圧ヘッド−(100cm ヘッド)mbar;STM4507
(4)通気性 STM3801(38cm 2ヘッド)cfm
E481及びPVPは、水溶性ポリマーであり、表面活性に乏しい。しかし、E481及びPVPは、良好な膜及び良好な粘度を増加させる物質である。膜形成、低い表面張力の減少、及び高い組成粘度の組み合わせにより、処理組成物がSMS基材のバルク中に流れ込むことを制限することができる。その結果、水圧ヘッド試験で測定したときに、SMSのバリア特性にあまり影響を与えることなく処理することができる。
Claims (14)
- 抗微生物性組成物の均一なコーティングで少なくとも部分的に被覆された表面を有する基材を備える保護用物品であって、
前記抗微生物性組成物は、第1抗微生物性物質と、第2坑微生物性物質とを含有し、
前記第1抗微生物性物質は、ポリヘキサメチレン・ビグアニド(PHMB)から成り、
前記第2抗微生物性物質は、PG−ヒドロキシエチルセルロース塩化ココジモニウム、オクタデシルアミノジメチルカリメトキシシリルプロピル塩化アンモニウム、若しくはN−アルキル・プリグリコシド、又はこれらの組み合わせであることを特徴とする保護用物品。 - 請求項1に記載の保護用物品であって、
前記第1及び第2の抗微生物性物質はそれぞれ、1000:1〜1:1000の範囲の比で存在することを特徴とする保護用物品。 - 請求項1に記載の保護用物品であって、
当該保護用物品が、ガウン、ローブ、フェイス・マスク、ヘッドカバー、靴カバー、及び手袋を含む衣類であることを特徴とする保護用物品。 - 請求項1に記載の保護用物品であって、
当該保護用物品が、手術着、手術用開窓若しくはカバー、ドレープ、シーツ、リネン、パッド、又はガーゼ包帯であることを特徴とする保護用物品。 - 請求項1に記載の保護用物品であって、
前記抗微生物性組成物が、坑静電気剤と、フッ素ポリマーとを更に含むことを特徴とする保護用物品。 - 請求項5に記載の保護用物品であって、
前記坑静電気剤が、アクリル系のコポリマー化合物及びイソプロピル・アルコールを、又は塩酸グアニジン及びソルビトールを含むことを特徴とする保護用物品。 - 抗微生物性コーティングで少なくとも一部が被覆された基材を有する物品であって、
前記抗微生物性コーティングは、
前記基材上に存在する活性物質に対する重量%が、
0.05〜99.9重量%のポリヘキサメチレン・ビグアニド(PHMB)と、
0.05〜99.9重量%の少なくても1つのポリヘキサメチレン・ビグアニド(PHMB)以外の抗微生物性物質との混合物を含有し、
前記少なくても1つのポリヘキサメチレン・ビグアニド(PHMB)以外の抗微生物性物質は、PG−ヒドロキシエチルセルロース塩化ココジモニウム、オクタデシルアミノジメチルカリメトキシシリルプロピル塩化アンモニウム、若しくはN−アルキル・プリグリコシド、又はこれらの組み合わせであることを特徴とする物品。 - 請求項7に記載の物品であって、
前記混合物は、抗静電気剤とフッ素ポリマーとをさらに含むことを特徴とする物品。 - 請求項8に記載の物品であって、
前記坑静電気剤が、アクリル系のコポリマー化合物及びイソプロピル・アルコールを、又は、塩酸グアニジン及びソルビトールを含むことを特徴とする物品。 - 請求項7に記載の物品であって、
前記PHMBは、前記基材上に、0.05〜5重量%の範囲の最終濃度で存在することを特徴とする物品。 - 請求項7に記載の物品であって、
前記基材の少なくとも一部は、織布材料又は不織布材料で作成されていることを特徴とする物品。 - 請求項11に記載の物品であって、
前記基材の少なくとも一部は、前記織布材料で作成され、
前記織布材料は、天然繊維、又は、天然繊維と合成繊維との混合物から作成されることを特徴とする物品。 - 請求項11に記載の物品であって、
前記基材の少なくとも一部は、前記不織布材料で作成され、
前記不織布材料は、弾性又は非弾性の熱可塑性ポリマーを含むことを特徴とする物品。 - 請求項7に記載の物品であって、
前記抗微生物性コーティングは、30分以内に、当該物品と接触した黄色ブドウ球菌(ATCC27660)、黄色ブドウ球菌(MRSA ATCC 33591)、肺炎桿菌(ATCC 4352)、ライノウイルス1A (ATCC VR−1164)、インフエンザA (ATCC VR−1469)又はカンジダ菌(ATCC 10231)のいずれかの微生物の表面から他の面への接触伝播の1.4log10CFUの減少を示すことを特徴とする物品。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/216,341 | 2005-08-31 | ||
US11/216,341 US20070048356A1 (en) | 2005-08-31 | 2005-08-31 | Antimicrobial treatment of nonwoven materials for infection control |
PCT/US2006/033980 WO2007027858A2 (en) | 2005-08-31 | 2006-08-31 | Antimicrobial treatment of nonwoven materials for infection control |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2009510270A JP2009510270A (ja) | 2009-03-12 |
JP2009510270A5 JP2009510270A5 (ja) | 2009-11-26 |
JP4999847B2 true JP4999847B2 (ja) | 2012-08-15 |
Family
ID=37773000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008529261A Expired - Fee Related JP4999847B2 (ja) | 2005-08-31 | 2006-08-31 | 感染防止のための不織布材料の抗微生物処理 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20070048356A1 (ja) |
EP (1) | EP1943302B1 (ja) |
JP (1) | JP4999847B2 (ja) |
CA (1) | CA2619446C (ja) |
DE (1) | DE602006011930D1 (ja) |
MX (1) | MX2008002792A (ja) |
WO (1) | WO2007027858A2 (ja) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090235933A1 (en) * | 2008-08-26 | 2009-09-24 | Trutek Corp. | Electrostatically charged mask filter products and method for increased filtration efficiency |
US20070048344A1 (en) * | 2005-08-31 | 2007-03-01 | Ali Yahiaoui | Antimicrobial composition |
US20070048358A1 (en) * | 2005-08-31 | 2007-03-01 | Schorr Phillip A | Antimicrobial substrates |
US20070048345A1 (en) * | 2005-08-31 | 2007-03-01 | Kimberly-Clark Worldwide, Inc. | Antimicrobial composition |
US9247736B2 (en) * | 2005-12-14 | 2016-02-02 | 3M Innovative Properties Company | Antimicrobial adhesive films |
US20070134303A1 (en) * | 2005-12-14 | 2007-06-14 | Ali Yahiaoui | Protective and therapeutic article |
US20100240799A1 (en) * | 2007-06-13 | 2010-09-23 | 3M Innovative Properties Company | Antimicrobial film-forming composition, antimicrobial film, and method of verifying the presence of an antimicrobial film |
WO2010008822A2 (en) | 2008-06-23 | 2010-01-21 | Adhezion Biomedical, Llc | Cyanoacrylate tissue adhesives with desirable permeability and tensile strength |
US8729121B2 (en) * | 2007-06-25 | 2014-05-20 | Adhezion Biomedical, Llc | Curing accelerator and method of making |
US8613952B2 (en) * | 2007-11-14 | 2013-12-24 | Adhezion Biomedical, Llc | Cyanoacrylate tissue adhesives |
US20090149792A1 (en) * | 2007-12-06 | 2009-06-11 | Kreetech International Corp. | Composition for wound management |
WO2009085570A2 (en) * | 2007-12-21 | 2009-07-09 | 3M Innovative Properties Company | Antimicrobial cellulose sponge and method of making |
US8198344B2 (en) * | 2008-06-20 | 2012-06-12 | Adhezion Biomedical, Llc | Method of preparing adhesive compositions for medical use: single additive as both the thickening agent and the accelerator |
US8753561B2 (en) * | 2008-06-20 | 2014-06-17 | Baxter International Inc. | Methods for processing substrates comprising metallic nanoparticles |
US8178120B2 (en) * | 2008-06-20 | 2012-05-15 | Baxter International Inc. | Methods for processing substrates having an antimicrobial coating |
US8293838B2 (en) * | 2008-06-20 | 2012-10-23 | Adhezion Biomedical, Llc | Stable and sterile tissue adhesive composition with a controlled high viscosity |
US8277826B2 (en) * | 2008-06-25 | 2012-10-02 | Baxter International Inc. | Methods for making antimicrobial resins |
EP2303770B1 (en) * | 2008-06-30 | 2014-07-09 | 3M Innovative Properties Company | Method for in situ formation of metal nanoclusters within a porous substrate |
US20090324738A1 (en) * | 2008-06-30 | 2009-12-31 | Baxter International Inc. | Methods for making antimicrobial coatings |
US20100030170A1 (en) * | 2008-08-01 | 2010-02-04 | Keith Alan Keller | Absorptive Pad |
US9533479B2 (en) | 2008-09-18 | 2017-01-03 | Medline Industries, Inc. | Absorbent articles having antimicrobial properties and methods of manufacturing the same |
WO2010033794A1 (en) * | 2008-09-19 | 2010-03-25 | 3M Innovative Properties Company | Ligand graft functionalized substrates |
US20100088827A1 (en) * | 2008-10-13 | 2010-04-15 | G & K Services, Inc. | Providing a rechargeable halogen-binding fabric to customers |
US8652510B2 (en) | 2008-10-31 | 2014-02-18 | Adhezion Biomedical, Llc | Sterilized liquid compositions of cyanoacrylate monomer mixtures |
US9254133B2 (en) | 2008-10-31 | 2016-02-09 | Adhezion Biomedical, Llc | Sterilized liquid compositions of cyanoacrylate monomer mixtures |
US8609128B2 (en) * | 2008-10-31 | 2013-12-17 | Adhezion Biomedical, Llc | Cyanoacrylate-based liquid microbial sealant drape |
BRPI0921066A2 (pt) * | 2008-11-20 | 2015-12-15 | Water Visions International Inc | composição, método para inativar contaminantes microbiológicos em um fluido, método para fabricar um material polimérico antimicrobiano, e, dispositivo para tratamento antimicrobiano de um fluido |
US20100227052A1 (en) * | 2009-03-09 | 2010-09-09 | Baxter International Inc. | Methods for processing substrates having an antimicrobial coating |
US9717818B2 (en) | 2009-05-08 | 2017-08-01 | Medline Industries, Inc. | Absorbent articles having antimicrobial properties and methods of manufacturing the same |
DE102009029762A1 (de) * | 2009-06-18 | 2010-12-23 | Paul Hartmann Ag | Polymerer medizinischer oder medizintechnischer oder PSA-Artikel mit antimikrobieller Ausrüstung |
US20110086078A1 (en) * | 2009-10-14 | 2011-04-14 | Water Visions International, Inc. | Fibrous antimicrobial materials, structures, and barrier applications |
US20130053439A1 (en) * | 2009-11-24 | 2013-02-28 | Barbara Kirschner | Disinfectant composition |
GB201003531D0 (en) * | 2010-03-03 | 2010-04-21 | Arcis Biotechnology Ltd | Composition and method |
KR20130094686A (ko) * | 2010-04-12 | 2013-08-26 | 바스프 에스이 | 합성 부직 텍스타일의 항미생물성 처리 |
US9309019B2 (en) | 2010-05-21 | 2016-04-12 | Adhezion Biomedical, Llc | Low dose gamma sterilization of liquid adhesives |
WO2012018736A1 (en) * | 2010-08-02 | 2012-02-09 | Triomed Innovations Corp. | Polymer films with embedded iodinated resin and methods of manufacturing same |
WO2012108480A1 (ja) * | 2011-02-10 | 2012-08-16 | 大幸薬品株式会社 | 殺虫剤、及び殺虫方法 |
WO2012136757A1 (en) | 2011-04-08 | 2012-10-11 | Basf Se | Process for the treatment of synthetic textiles with cationic biocides |
CN102230279B (zh) * | 2011-05-11 | 2013-02-06 | 武汉纺织大学 | 一种制备单面免烫纺织品的方法 |
AU2012271161B2 (en) | 2011-06-13 | 2015-11-26 | Dow Global Technologies Llc | Biocidal Compositions and Methods of Use |
GB201118673D0 (en) * | 2011-10-28 | 2011-12-14 | Byotrol Plc | Anti-microbial composition |
WO2013115063A1 (ja) * | 2012-01-31 | 2013-08-08 | Vbジャパンテクノロジー株式会社 | リネン製品の製造方法及びクリーニング方法 |
WO2013121222A1 (en) * | 2012-02-16 | 2013-08-22 | Arcis Biotechnology Limited | Coating compositions and methods |
US8545951B2 (en) | 2012-02-29 | 2013-10-01 | Kimberly-Clark Worldwide, Inc. | Endotracheal tubes and other polymer substrates including an anti-fouling treatment |
US20130344122A1 (en) * | 2012-06-25 | 2013-12-26 | Allegiance Corporation | Nonwoven materials containing chlorhexidine acetate and triclosan |
GB2504666B (en) * | 2012-07-23 | 2017-06-07 | Clinisupplies Ltd | A garment |
JP2016512963A (ja) * | 2012-12-11 | 2016-05-12 | イノベイティブ トラウマ ケア インコーポレイテッド | 止血手袋装置およびその使用方法 |
JP2016511037A (ja) * | 2013-02-21 | 2016-04-14 | クリーンスポット インコーポレイテッド | 衛生状態を改善するための頻繁に触れられる表面の処理 |
US20140273689A1 (en) * | 2013-03-15 | 2014-09-18 | Allegiance Corporation | Nonwoven materials coated with fluoropolymer and antimicrobial agent |
EP3013146B1 (en) | 2013-06-28 | 2020-11-25 | 3M Innovative Properties Company | Wipe with a guanidinyl-containing polymer |
IN2013MU02827A (ja) | 2013-08-29 | 2015-07-03 | Green Impact Holdings Gmbh | |
JP6554474B2 (ja) | 2014-01-24 | 2019-07-31 | アヴェント インコーポレイテッド | ラップを含む外傷性創傷ドレッシングシステム |
MX369133B (es) | 2014-01-24 | 2019-10-30 | Avent Inc | Sistema de vendaje para heridas traumaticas con cubierta de conformacion. |
GB2524306B (en) * | 2014-03-20 | 2016-03-16 | Dycem Ltd | Contamination control mat |
US9421297B2 (en) | 2014-04-02 | 2016-08-23 | Adhezion Biomedical, Llc | Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides |
CN105194720B (zh) * | 2014-06-20 | 2018-06-19 | 崔鹏涛 | 一种具有自洁调理功能的材料及卫生产品 |
BR102014030351A8 (pt) * | 2014-12-04 | 2021-03-16 | Cardoso De Gouveia Alberto | composição dermatológica e seu uso |
WO2016135344A1 (en) * | 2015-02-27 | 2016-09-01 | Green Impact Holding Ag | Textiles having antimicrobial properties |
EP3061864A1 (en) * | 2015-02-27 | 2016-08-31 | Green Impact Holding AG | Textiles having antimicrobial properties |
JP2017106126A (ja) * | 2015-12-07 | 2017-06-15 | 東洋紡株式会社 | 防護材料 |
TWM532478U (zh) * | 2016-07-15 | 2016-11-21 | 馗鼎奈米科技股份有限公司 | 織品之疏水整理設備 |
CN109983172A (zh) * | 2016-09-19 | 2019-07-05 | 格拉姆工业有限公司 | 抗菌再生纤维素纤维及其制备方法 |
WO2018068100A1 (en) * | 2016-10-14 | 2018-04-19 | Commonwealth Scientific And Industrial Research Organisation | Antimicrobial triboelectric material |
CN107805906A (zh) * | 2017-11-29 | 2018-03-16 | 新乡市新科防护科技有限公司 | 一种布料染色用防褶皱装置 |
WO2020035722A1 (en) * | 2018-08-17 | 2020-02-20 | O&M Halyard International Unlimited Company | Wettable sms material for personal protective equipment applications |
WO2020040781A1 (en) | 2018-08-24 | 2020-02-27 | Avent, Inc. | Polymeric hydroperoxides as oxygen delivery agents |
WO2020040785A1 (en) | 2018-08-24 | 2020-02-27 | Avent, Inc. | Formulations for generating oxygen |
WO2020040783A1 (en) | 2018-08-24 | 2020-02-27 | Avent, Inc. | Polyurethanes as oxygen delivery carriers |
CN109381480B (zh) * | 2018-11-15 | 2021-02-09 | 江苏聚锦生物医疗科技有限责任公司 | 复配聚六亚甲基双胍消毒液及其制备方法 |
US20210213702A1 (en) * | 2019-12-17 | 2021-07-15 | Saint-Gobain Abrasives, Inc. | Nonwoven article |
US20220007761A1 (en) * | 2020-07-10 | 2022-01-13 | Botron Co., Inc. | Anti-Static Personal Protective Equipment |
CN112006028A (zh) * | 2020-07-29 | 2020-12-01 | 合肥皖科凌霄环境科技合伙企业(有限合伙) | 一种含有钛基固体酸空气杀菌剂的制备方法 |
CN112479392B (zh) * | 2020-11-23 | 2021-08-27 | 纳琦绿能工程有限公司 | 一种复合污水处理剂及其制备方法和应用 |
KR102323867B1 (ko) * | 2020-11-30 | 2021-11-09 | 주식회사 마스코 | 기능성 의료 마스크 및 그 제조방법 |
KR102323864B1 (ko) * | 2020-11-30 | 2021-11-09 | 주식회사 마스코 | 기능성 면 마스크 및 그 제조방법 |
KR102272572B1 (ko) * | 2020-11-30 | 2021-07-05 | 주식회사 마스코 | 기능성 3d 마스크 및 그 제조방법 |
BR112023017642A2 (pt) * | 2021-03-31 | 2023-10-10 | Kimberly Clark Co | Composição de lenço umedecido antimicrobiano, produto de consumo, método para preservar uma formulação de lenço umedecido, e, método de fabricação de uma formulação de lenço umedecido |
DE102021109834A1 (de) | 2021-04-19 | 2022-10-20 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein | Zusammensetzung zur Desinfektion und für kosmetische Anwendungen |
Family Cites Families (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3494821A (en) * | 1967-01-06 | 1970-02-10 | Du Pont | Patterned nonwoven fabric of hydraulically entangled textile fibers and reinforcing fibers |
US3730701A (en) * | 1971-05-14 | 1973-05-01 | Method for controlling the growth of algae in an aqueous medium | |
US3719697A (en) * | 1971-09-29 | 1973-03-06 | Dow Corning | Tris-trimethylsiloxy amines |
GB1453447A (en) * | 1972-09-06 | 1976-10-20 | Kimberly Clark Co | Nonwoven thermoplastic fabric |
GB1550955A (en) * | 1975-12-29 | 1979-08-22 | Johnson & Johnson | Textile fabric and method of manufacturing the same |
US4215682A (en) * | 1978-02-06 | 1980-08-05 | Minnesota Mining And Manufacturing Company | Melt-blown fibrous electrets |
US4467799A (en) * | 1980-05-05 | 1984-08-28 | Steinberg Jacob H | Transparent odor-free face mask |
US4375718A (en) * | 1981-03-12 | 1983-03-08 | Surgikos, Inc. | Method of making fibrous electrets |
US4897304A (en) * | 1981-07-20 | 1990-01-30 | Kimberly-Clark Corporation | Virucidal composition, the method of use and the product therefor |
US4828912A (en) * | 1981-07-20 | 1989-05-09 | Kimberly-Clark Corporation | Virucidal product having virucidal and/or germicidal properties |
US4374888A (en) * | 1981-09-25 | 1983-02-22 | Kimberly-Clark Corporation | Nonwoven laminate for recreation fabric |
US4395454A (en) * | 1981-10-09 | 1983-07-26 | Burlington Industries, Inc. | Absorbent microbiocidal fabric and product |
US4587266A (en) * | 1982-09-24 | 1986-05-06 | Johnson & Johnson Baby Products Company | Antimicrobial compositions |
FR2552305B1 (fr) * | 1983-09-22 | 1985-12-20 | Salkin Andre | Composition a pouvoir bactericide eleve contenant un biguanide et une pyrimidine |
US4675347A (en) * | 1983-10-29 | 1987-06-23 | Unitika Ltd. | Antimicrobial latex composition |
JPS60168511A (ja) * | 1984-02-10 | 1985-09-02 | Japan Vilene Co Ltd | エレクトレツトフイルタの製造方法 |
GB8422070D0 (en) * | 1984-08-31 | 1984-10-03 | Ici Plc | Treated non-woven material |
US4721511A (en) * | 1984-10-05 | 1988-01-26 | W. R. Grace & Co. | Leach resistant antimicrobial fabric |
US4874659A (en) * | 1984-10-24 | 1989-10-17 | Toray Industries | Electret fiber sheet and method of producing same |
US4643180A (en) * | 1985-02-28 | 1987-02-17 | Surgikos, Inc. | Antimicrobial dressing |
US4856509A (en) * | 1985-07-08 | 1989-08-15 | Lemelson Jerome H | Face mask and method |
US4615937A (en) * | 1985-09-05 | 1986-10-07 | The James River Corporation | Antimicrobially active, non-woven web used in a wet wiper |
US4643181A (en) * | 1986-04-04 | 1987-02-17 | Surgikos, Inc. | Antimicrobial dressing or drape material |
US4766029A (en) * | 1987-01-23 | 1988-08-23 | Kimberly-Clark Corporation | Semi-permeable nonwoven laminate |
US4853978A (en) * | 1987-07-24 | 1989-08-08 | Surgikos, Inc. | Antimicrobial medical glove |
US5141803A (en) * | 1988-06-29 | 1992-08-25 | Sterling Drug, Inc. | Nonwoven wipe impregnating composition |
IL90554A0 (en) * | 1988-06-29 | 1990-01-18 | Sterling Drug Inc | Compositions containing preservative systems and nonwoven wipes impregnated therewith |
US4837079A (en) * | 1988-09-09 | 1989-06-06 | James River Corporation | Antimicrobially active, non-woven web used in a wet wiper |
US5169706A (en) * | 1990-01-10 | 1992-12-08 | Kimberly-Clark Corporation | Low stress relaxation composite elastic material |
US5069907A (en) * | 1990-03-23 | 1991-12-03 | Phoenix Medical Technology | Surgical drape having incorporated therein a broad spectrum antimicrobial agent |
US5464688A (en) * | 1990-06-18 | 1995-11-07 | Kimberly-Clark Corporation | Nonwoven web laminates with improved barrier properties |
US5213881A (en) * | 1990-06-18 | 1993-05-25 | Kimberly-Clark Corporation | Nonwoven web with improved barrier properties |
US5158763A (en) * | 1990-10-09 | 1992-10-27 | Colgate-Palmolive Company | Non-staining anti-bacterial oral composition |
US5112900A (en) * | 1990-11-28 | 1992-05-12 | Tactyl Technologies, Inc. | Elastomeric triblock copolymer compositions and articles made therewith |
US5407715A (en) * | 1990-11-28 | 1995-04-18 | Tactyl Technologies, Inc. | Elastomeric triblock copolymer compositions and articles made therewith |
CA2048905C (en) * | 1990-12-21 | 1998-08-11 | Cherie H. Everhart | High pulp content nonwoven composite fabric |
US5176901A (en) * | 1991-04-10 | 1993-01-05 | Smithkline Beecham Corporation | Dental composition |
US5300167A (en) * | 1992-01-03 | 1994-04-05 | Kimberly-Clark | Method of preparing a nonwoven web having delayed antimicrobial activity |
US5401446A (en) * | 1992-10-09 | 1995-03-28 | The University Of Tennessee Research Corporation | Method and apparatus for the electrostatic charging of a web or film |
IT1272109B (it) * | 1993-03-19 | 1997-06-11 | Eniricerche Spa | Processo per la preparazione di apg |
US5567372A (en) * | 1993-06-11 | 1996-10-22 | Kimberly-Clark Corporation | Method for preparing a nonwoven web containing antimicrobial siloxane quaternary ammonium salts |
GB9322132D0 (en) * | 1993-10-27 | 1993-12-15 | Zeneca Ltd | Antimicrobial treatment of textile materials |
US5849311A (en) * | 1996-10-28 | 1998-12-15 | Biopolymerix, Inc. | Contact-killing non-leaching antimicrobial materials |
US5869073A (en) * | 1993-12-20 | 1999-02-09 | Biopolymerix, Inc | Antimicrobial liquid compositions and methods for using them |
US5817325A (en) * | 1996-10-28 | 1998-10-06 | Biopolymerix, Inc. | Contact-killing antimicrobial devices |
US6136298A (en) * | 1994-07-14 | 2000-10-24 | Colgate-Palmolive Company | Process for inhibiting S. mutans and caries |
US5908598A (en) * | 1995-08-14 | 1999-06-01 | Minnesota Mining And Manufacturing Company | Fibrous webs having enhanced electret properties |
US5792531A (en) * | 1996-02-20 | 1998-08-11 | Tactyl Technologies, Inc. | Readily donned, powder free elastomeric article |
JPH09324366A (ja) * | 1996-06-03 | 1997-12-16 | Ikari Shodoku Kk | 伸縮性カバー |
US5900452A (en) * | 1996-08-12 | 1999-05-04 | Tactyl Technologies, Inc. | S-EB-S block copolymer/oil aqueous dispersion and its use in forming articles |
US5770543A (en) * | 1996-09-06 | 1998-06-23 | Henkel Corporation | Agricultural compositions comprising alkyl polyglycosides and fatty acids |
US5883026A (en) * | 1997-02-27 | 1999-03-16 | Kimberly-Clark Worldwide, Inc. | Face masks including a spunbonded/meltblown/spunbonded laminate |
JP3275032B2 (ja) * | 1997-03-03 | 2002-04-15 | 独立行政法人産業技術総合研究所 | 環境浄化材料及びその製造方法 |
US6315864B2 (en) * | 1997-10-30 | 2001-11-13 | Kimberly-Clark Worldwide, Inc. | Cloth-like base sheet and method for making the same |
US6197322B1 (en) * | 1997-12-23 | 2001-03-06 | Kimberly-Clark Worldwide, Inc. | Antimicrobial structures |
WO1999040791A1 (en) * | 1998-02-12 | 1999-08-19 | Surfacine Development Company, Llc | Disinfectant compositions providing sustained biocidal action |
RU2241489C2 (ru) * | 1998-02-27 | 2004-12-10 | Биора Биоэкс Аб | Композиции матриксных протеинов для залечивания ран |
US6365088B1 (en) * | 1998-06-26 | 2002-04-02 | Kimberly-Clark Worldwide, Inc. | Electret treatment of high loft and low density nonwoven webs |
GB9817457D0 (en) * | 1998-08-12 | 1998-10-07 | Reckitt & Colman Inc | Improvements in or related to organic compositions |
DE60006227T2 (de) * | 1999-05-21 | 2004-08-05 | 3M Innovative Properties Co., Saint Paul | Antimikrobielle gegenstände |
CN1468298A (zh) * | 1999-10-22 | 2004-01-14 | 用于处理鞋子的组合物和采用它的方法和制品 | |
US6303557B1 (en) * | 1999-11-16 | 2001-10-16 | S. C. Johnson Commercial Markets, Inc. | Fast acting disinfectant and cleaner containing a polymeric biguanide |
EP1289367B1 (en) * | 2000-06-02 | 2006-03-22 | Arch Chemicals, Inc. | Treatment of circulating water systems |
US6485950B1 (en) * | 2000-07-14 | 2002-11-26 | Council Of Scientific And Industrial Research | Isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD in cosmetic, food and pharmaceutical compositions |
US6767508B1 (en) * | 2000-11-28 | 2004-07-27 | Kimberly-Clark Worldwide, Inc. | Nonwovens modified with alkyl polyglycoside surfactants |
US20020183233A1 (en) * | 2000-12-14 | 2002-12-05 | The Clorox Company, Delaware Corporation | Bactericidal cleaning wipe |
DK1377280T3 (da) * | 2001-04-09 | 2007-10-08 | Danisco Usa Inc | Fyldmidler som mæthedsfornemmelsesgivende midler |
ATE364684T1 (de) * | 2001-10-09 | 2007-07-15 | Procter & Gamble | Befeuchtetes wischtuch enthaltend polymere biguanidverbindungen für die behandelung von oberflächen |
US6712121B2 (en) * | 2001-10-12 | 2004-03-30 | Kimberly-Clark Worldwide, Inc. | Antimicrobially-treated fabrics |
FR2833173B1 (fr) * | 2001-12-10 | 2004-08-27 | Roquette Freres | Preparation antipyretique renfermant du xylitol |
US6835865B2 (en) * | 2001-12-21 | 2004-12-28 | Kimberly-Clark Worldwide, Inc. | Antimicrobial nonwoven webs for personal care absorbent articles |
FI20020078A (fi) * | 2002-01-15 | 2003-07-16 | Danisco | Immuunijärjestelmän stimulointi polydextroosilla |
US6838078B2 (en) * | 2002-01-16 | 2005-01-04 | 3M Innovative Properties Company | Film-forming compositions and methods |
JP4902929B2 (ja) * | 2002-03-28 | 2012-03-21 | 住化エンビロサイエンス株式会社 | 工業用抗菌組成物及び抗菌方法 |
US20030204180A1 (en) * | 2002-04-30 | 2003-10-30 | Kimberly-Clark Worldwide, Inc. | Temperature responsive delivery systems |
US7201914B2 (en) * | 2002-05-17 | 2007-04-10 | Xantech Pharmaceuticals, Inc. | Combination antiperspirant and antimicrobial composition |
US8349301B2 (en) * | 2002-06-04 | 2013-01-08 | The Procter & Gamble Company | Shampoo containing a gel network |
US8100872B2 (en) * | 2002-10-23 | 2012-01-24 | Tyco Healthcare Group Lp | Medical dressing containing antimicrobial agent |
JP2004149000A (ja) * | 2002-10-30 | 2004-05-27 | Showa Corp | 船舶用ガスシリンダ装置 |
JP2004188091A (ja) * | 2002-12-13 | 2004-07-08 | Daio Paper Corp | 拭取り用シート |
US7550418B2 (en) * | 2002-12-13 | 2009-06-23 | Novartis Ag | Lens care composition and method |
US20040151919A1 (en) * | 2003-01-31 | 2004-08-05 | Kimberly-Clark Worldwide, Inc. | Glove having reduced microbe affinity and transmission |
JP2006104632A (ja) * | 2004-10-08 | 2006-04-20 | Nicca Chemical Co Ltd | 繊維製品の抗菌加工方法および抗菌性繊維製品 |
US7619008B2 (en) * | 2004-11-12 | 2009-11-17 | Kimberly-Clark Worldwide, Inc. | Xylitol for treatment of vaginal infections |
US20060110997A1 (en) * | 2004-11-24 | 2006-05-25 | Snowden Hue S | Treated nonwoven fabrics and method of treating nonwoven fabrics |
US20070048358A1 (en) * | 2005-08-31 | 2007-03-01 | Schorr Phillip A | Antimicrobial substrates |
US20070048344A1 (en) * | 2005-08-31 | 2007-03-01 | Ali Yahiaoui | Antimicrobial composition |
-
2005
- 2005-08-31 US US11/216,341 patent/US20070048356A1/en not_active Abandoned
-
2006
- 2006-08-31 WO PCT/US2006/033980 patent/WO2007027858A2/en active Application Filing
- 2006-08-31 CA CA2619446A patent/CA2619446C/en not_active Expired - Fee Related
- 2006-08-31 MX MX2008002792A patent/MX2008002792A/es active IP Right Grant
- 2006-08-31 JP JP2008529261A patent/JP4999847B2/ja not_active Expired - Fee Related
- 2006-08-31 EP EP06824863A patent/EP1943302B1/en not_active Expired - Fee Related
- 2006-08-31 DE DE602006011930T patent/DE602006011930D1/de active Active
Also Published As
Publication number | Publication date |
---|---|
EP1943302A2 (en) | 2008-07-16 |
CA2619446A1 (en) | 2007-03-08 |
EP1943302B1 (en) | 2010-01-20 |
WO2007027858A3 (en) | 2007-04-26 |
WO2007027858A2 (en) | 2007-03-08 |
US20070048356A1 (en) | 2007-03-01 |
JP2009510270A (ja) | 2009-03-12 |
CA2619446C (en) | 2014-06-17 |
DE602006011930D1 (de) | 2010-03-11 |
MX2008002792A (es) | 2008-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4999847B2 (ja) | 感染防止のための不織布材料の抗微生物処理 | |
JP2009505804A (ja) | 抗微生物性組成物 | |
JP2009506128A (ja) | 抗微生物性組成物 | |
US9901128B2 (en) | Antimicrobial apparel and fabric and coverings | |
JP4823314B2 (ja) | 殺菌性フェイスマスク | |
TWI378773B (en) | Antimicrobial compositions and fibres incorporating the same | |
US20070141126A1 (en) | Germicidal surface-covering assembly | |
US10182946B2 (en) | Advanced fabric technology and filters | |
BR112021010135A2 (pt) | Tecido têxtil, não tecido (tnt), algodão, algodão misto, máscaras de polietileno e polipropileno e poliestireno, penso para ferimentos, calcinha, sutiã, lenço, esponja, esfregão, avental cirúrgico descartável, lençóis descartáveis com propriedades antimicrobianas | |
US20120087962A1 (en) | Novel article | |
US11352715B2 (en) | Active apparel and fabric and coverings | |
MX2008002848A (en) | Antimicrobial substrates | |
US20230167601A1 (en) | Antimicrobial textiles | |
US20220403588A1 (en) | The chemical composition for impregnation via spraying on disposable sugical masks, sleeves gowns made from hydrophilic and hydrophobic materials for the inactivation of bacteria and viruses such as coronavirus, sars, mers, influenza a and influenza b viruses | |
Periyasamy et al. | Protection against Microbes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090610 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091006 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110713 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110719 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20111019 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20111026 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111121 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120207 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20120208 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120419 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120515 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120515 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4999847 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150525 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |